Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Liver Disease (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03089944
What this trial is testing

Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 343
Large-scale testing (Phase 3)Study completedNCT00412529
What this trial is testing

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hepatitis B
Novartis Pharmaceuticals 44
Not applicableNot Yet RecruitingNCT07842666
What this trial is testing

Baveno VIII Criteria for Portal Hypertension in Egyptian Patients

Who this might be right for
Compensated Liver DiseaseEsophageal VaricesPortal Hypertension+1 more
Assiut University 125
Large-scale testing (Phase 3)UnknownNCT06434753
What this trial is testing

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Who this might be right for
Advanced Chronic Liver DiseasePortal HypertensionHepatocellular Carcinoma
Hospital Universitari Vall d'Hebron Research Institute 300
Testing effectiveness (Phase 2)Study completedNCT01409356
What this trial is testing

Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis

Who this might be right for
Compensated CirrhosisObesity
Hospital Clinic of Barcelona 60
Not applicableLooking for participantsNCT07122622
What this trial is testing

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Who this might be right for
Portal Hypertension Related to CirrhosisEsophageal Varices
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 450
Not applicableUnknownNCT01720238
What this trial is testing

Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis

Who this might be right for
Liver CirrhosisHepatitis B
Beijing Friendship Hospital 621
Large-scale testing (Phase 3)Study completedNCT02023099
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 363
Early research (Phase 1)Study completedNCT05022693
What this trial is testing

PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 8
Post-approval studies (Phase 4)Study completedNCT01943617
What this trial is testing

Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Beijing Friendship Hospital 606
Large-scale testing (Phase 3)Study completedNCT01475851
What this trial is testing

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 34
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Post-approval studies (Phase 4)Ended earlyNCT00194857
What this trial is testing

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

Who this might be right for
AnemiaNeutropeniaHepatitis C Virus+1 more
Weill Medical College of Cornell University
Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Post-approval studies (Phase 4)WithdrawnNCT00606099
What this trial is testing

Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Not applicableUnknownNCT06147934
What this trial is testing

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD

Who this might be right for
Liver FibrosisLiver Cirrhosis
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableUnknownNCT04196998
What this trial is testing

Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis

Who this might be right for
Hepatitis BCompensated Cirrhosis
Third Affiliated Hospital, Sun Yat-Sen University 150
Testing effectiveness (Phase 2)Study completedNCT05039450
What this trial is testing

Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 213
Not applicableStudy completedNCT05653115
What this trial is testing

Portal Hypetension and Bariatric Surgery (BARIAPORTAL)

Who this might be right for
Bariatric Surgery CandidateObesity, MorbidPortal Hypertension
Centre Hospitalier Universitaire de Nice 63
Large-scale testing (Phase 3)Study completedNCT02265237
What this trial is testing

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

Who this might be right for
Hepatitis C Virus
AbbVie 184
Next Page